In this panel we hear from active medtech angels, family office, and other non-traditional early stage investors. What are they investing in? What are they bringing to the table besides capital? What kind of deals are they interested in right now?
This group of panelists represent a new CrowdSourcing & Direct Investment Platform, 4 Lifescience Angel Groups, 2 Family Offices, and a new VC fund focused exclusively on early-stage deals.
Panelists include:
Rob Ball, Managing Partner, Genesis & Cutivate MD Fund
Greg Scott, Managing Partner, BioPacific Angel Investors
Brian Smith, CEO, RedCrow Direct Investment Platform
Ben Joseph, CEO, Mend Medical Investment Fund & Family Office
Dave Hood, CEO, Non-Dilutive Funding Source & DOD
The moderator is Irfan Lateff of Knobbe Martens.